Patent classifications
C07C251/68
Polymerizable compound, polymerizable composition, polymer, and optically anisotropic product
This polymerizable compound is represented by a formula (I), this polymerizable composition contains said polymerizable compound and a polymerization initiator, this polymer is obtained by polymerizing the polymerizable compound or polymerizable composition, and this optically anisotropic product is comprised from the polymer. In the formula, each of Y.sup.1 to Y.sup.8 represents O, S, OC(O), C(O)O, etc., Y.sup.a represents O, S, OC(O), C(O)O, etc., each of G.sup.1 and G.sup.2 represents a divalent linear aliphatic group having 1 to 20 carbon atoms, etc., each of Z.sup.1 and Z.sup.2 represents an alkenyl group having 2 to 10 carbon atoms, etc., A.sup.x represents an organic group having an aromatic ring and 2 to 30 carbon atoms, A.sup.1 represents a trivalent aromatic group, etc., each of A.sup.2 and A.sup.3 represents a divalent alicyclic hydrocarbon group having 3 to 30 carbon atoms, each of A.sup.4 and A.sup.5 represents a divalent aromatic group having 4 to 30 carbon atoms, etc., Q.sup.1 represents an alkyl group having 1 to 6 carbon atoms, etc., and each of m and n represents 0 or 1. ##STR00001##
Polymerizable compound, polymerizable composition, polymer, and optically anisotropic product
This polymerizable compound is represented by a formula (I), this polymerizable composition contains said polymerizable compound and a polymerization initiator, this polymer is obtained by polymerizing the polymerizable compound or polymerizable composition, and this optically anisotropic product is comprised from the polymer. In the formula, each of Y.sup.1 to Y.sup.8 represents O, S, OC(O), C(O)O, etc., Y.sup.a represents O, S, OC(O), C(O)O, etc., each of G.sup.1 and G.sup.2 represents a divalent linear aliphatic group having 1 to 20 carbon atoms, etc., each of Z.sup.1 and Z.sup.2 represents an alkenyl group having 2 to 10 carbon atoms, etc., A.sup.x represents an organic group having an aromatic ring and 2 to 30 carbon atoms, A.sup.1 represents a trivalent aromatic group, etc., each of A.sup.2 and A.sup.3 represents a divalent alicyclic hydrocarbon group having 3 to 30 carbon atoms, each of A.sup.4 and A.sup.5 represents a divalent aromatic group having 4 to 30 carbon atoms, etc., Q.sup.1 represents an alkyl group having 1 to 6 carbon atoms, etc., and each of m and n represents 0 or 1. ##STR00001##
POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC PRODUCT
This polymerizable compound is represented by a formula (I), this polymerizable composition contains said polymerizable compound and a polymerization initiator, this polymer is obtained by polymerizing the polymerizable compound or polymerizable composition, and this optically anisotropic product is comprised from the polymer. In the formula, each of Y.sup.1 to Y.sup.8 represents O, S, OC(O), C(O)O, etc., Y.sup.a represents O, S, OC(O), C(O)O, etc., each of G.sup.1 and G.sup.2 represents a divalent linear aliphatic group having 1 to 20 carbon atoms, etc., each of Z.sup.1 and Z.sup.2 represents an alkenyl group having 2 to 10 carbon atoms, etc., A.sup.x represents an organic group having an aromatic ring and 2 to 30 carbon atoms, A.sup.1 represents a trivalent aromatic group, etc., each of A.sup.2 and A.sup.3 represents a divalent alicyclic hydrocarbon group having 3 to 30 carbon atoms, each of A.sup.4 and A.sup.5 represents a divalent aromatic group having 4 to 30 carbon atoms, etc., Q.sup.1 represents an alkyl group having 1 to 6 carbon atoms, etc., and each of m and n represents 0 or 1.
##STR00001##
Hematopoietic growth factor mimetic small molecule compounds and their uses
The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.
Hematopoietic growth factor mimetic small molecule compounds and their uses
The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.